Consolidated Financial Statements

Bayer Group Consolidated Income Statements

 

 

Note

 

2017

 

2018

 

 

 

 

€ million

 

€ million

2017 figures restated

1

For definition see Combined Management Report, Chapter “Alternative Performance Measures Used by the Bayer Group”.

Net sales

 

[6]

 

35,015

 

39,586

Cost of goods sold

 

 

 

(11,382)

 

(17,010)

Gross profit

 

 

 

23,633

 

22,576

Selling expenses

 

 

 

(11,116)

 

(12,751)

Research and development expenses

 

 

 

(4,504)

 

(5,246)

General administration expenses

 

 

 

(2,026)

 

(2,728)

Other operating income

 

[7]

 

864

 

5,057

Other operating expenses

 

[8]

 

(948)

 

(2,994)

EBIT1

 

 

 

5,903

 

3,914

Equity-method income (loss)

 

[10]

 

20

 

68

Financial income

 

 

 

289

 

910

Financial expenses

 

 

 

(1,635)

 

(2,574)

Financial result

 

[10]

 

(1,326)

 

(1,596)

Income before income taxes

 

 

 

4,577

 

2,318

Income taxes

 

[11]

 

(1,329)

 

(607)

Income from continuing operations after income taxes

 

 

 

3,248

 

1,711

of which attributable to noncontrolling interest

 

 

 

(1)

 

16

of which attributable to Bayer AG stockholders

 

 

 

3,249

 

1,695

Income from discontinued operations after income taxes

 

[5]

 

4,846

 

of which attributable to noncontrolling interest

 

 

 

759

 

of which attributable to Bayer AG stockholders

 

 

 

4,087

 

Income after income taxes

 

 

 

8,094

 

1,711

of which attributable to noncontrolling interest

 

[12]

 

758

 

16

of which attributable to Bayer AG stockholders (net income)

 

 

 

7,336

 

1,695

 

 

 

 

 

 

Earnings per share

 

[13]

 

 

 

 

From continuing operations

 

[13]

 

 

 

 

Basic

 

 

 

3.67

 

1.80

Diluted

 

 

 

3.67

 

1.80

From discontinued operations

 

[13]

 

 

 

 

Basic

 

 

 

4.62

 

0.00

Diluted

 

 

 

4.62

 

0.00

From continuing and discontinued operations

 

[13]

 

 

 

 

Basic

 

 

 

8.29

 

1.80

Diluted

 

 

 

8.29

 

1.80

Compare to Last Year